Inflammation-related transcripts define "high" and "low" subgroups of individuals with schizophrenia and bipolar
Yunting Zhu1, Samantha J Owens2, Caitlin E Murphy2
1Department of Neuroscience & Physiology, Upstate Medical University, Syracuse, NY 13210, USA.
Abstract:
Dopamine dysregulation in schizophrenia may be associated with midbrain inflammation. Previously, we found elevated levels of pro-inflammatory cytokine mRNAs in the post-mortem midbrain of people with schizophrenia (46%) but not from unaffected controls (0%) using a brain cohort from Sydney, Australia. Here, we measured cytokine mRNAs and proteins in the midbrain in the Stanley Medical Research Institute (SMRI) array cohort (N = 105). We tested if the proportions of individuals with schizophrenia and with high inflammation can be replicated, and if individuals with bipolar disorder with elevated midbrain cytokines can be identified. mRNA levels of 7 immune transcripts from post-mortem midbrain tissue were measured via RT-PCR and two-step recursive clustering analysis was performed using 4 immune transcripts to define "high and low" inflammatory subgroups. The clustering predictors used were identical to our earlier midbrain study, and included: IL1B, IL6, TNF, and SERPINA3 mRNA levels. 46% of schizophrenia cases (16/35 SCZ), 6% of controls (2/33 CTRL), and 29% of bipolar disorder cases (10/35 BPD) were identified as belonging to the high inflammation (HI) subgroups [χ2 (2) = 13.54, p < 0.001]. When comparing inflammatory subgroups, all four mRNAs were significantly increased in SCZ-HI and BPD-HI compared to low inflammation controls (CTRL-LI) (p < 0.05). Additionally, protein levels of IL-1β, IL-6, and IL-18 were elevated in SCZ-HI and BPD-HI compared to all other low inflammatory subgroups (all p < 0.05). Surprisingly, TNF-α protein levels were unchanged according to subgroups. In conclusion, we determined that almost half of the individuals with schizophrenia were defined as having high inflammation in the midbrain, replicating our previous findings. Further, we detected close to one-third of those with bipolar disorder to be classified as having high inflammation. Elevations in some pro-inflammatory cytokine mRNAs (IL-1β and IL-6) were also found at the protein level, whereas TNF mRNA and protein levels were not concordant.
Insights
Midbrain inflammation is prevalent in nearly half of schizophrenia patients, replicating prior research. This study also identified significant midbrain inflammation in nearly one-third of bipolar disorder patients.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Dopamine dysregulation in schizophrenia is potentially linked to midbrain inflammation.
- Previous research indicated elevated pro-inflammatory cytokine mRNAs in the post-mortem midbrain of individuals with schizophrenia.
Purpose of the Study:
- To replicate findings of elevated midbrain inflammation in schizophrenia.
- To investigate midbrain inflammation in bipolar disorder.
- To measure cytokine mRNA and protein levels in the midbrain.
Main Methods:
- RT-PCR was used to measure immune transcript mRNA levels in post-mortem midbrain tissue.
- Two-step recursive clustering analysis, using IL1B, IL6, TNF, and SERPINA3 mRNA levels, defined high and low inflammatory subgroups.
- Cytokine protein levels were measured in the identified subgroups.
Main Results:
- Replicated previous findings: 46% of schizophrenia cases exhibited high midbrain inflammation.
- Identified high midbrain inflammation in 29% of bipolar disorder cases and 6% of controls.
- Elevated IL-1β and IL-6 mRNA and protein levels were observed in high inflammation schizophrenia and bipolar disorder subgroups compared to controls.
Conclusions:
- Midbrain inflammation is a significant finding in nearly half of schizophrenia cases.
- A substantial proportion of bipolar disorder cases also show evidence of midbrain inflammation.
- While IL-1β and IL-6 show concordant mRNA and protein elevation, TNF-α levels were not consistent between mRNA and protein.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Bipolar Disorder
Psychological and Sociocultural Causes of Schizophrenia
Neural Regulation


